Home Cart Sign in  
Chemical Structure| 4046-02-0 Chemical Structure| 4046-02-0

Structure of Ethyl ferulate
CAS No.: 4046-02-0

Chemical Structure| 4046-02-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ethyl Ferulate is a naturally occurring plant product which can induce heme oxygenase-1 and protect rat neurons against oxidative stress.

Synonyms: Ferulic Acid ethyl ester; Ethyl 4'-hydroxy-3'-methoxycinnamate; NSC 14879

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ethyl ferulate

CAS No. :4046-02-0
Formula : C12H14O4
M.W : 222.24
SMILES Code : C1=C(C=CC(=C1OC)O)C=CC(OCC)=O
Synonyms :
Ferulic Acid ethyl ester; Ethyl 4'-hydroxy-3'-methoxycinnamate; NSC 14879
MDL No. :MFCD00009190
InChI Key :ATJVZXXHKSYELS-FNORWQNLSA-N
Pubchem ID :736681

Safety of Ethyl ferulate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
ARPE-19 cells 0.02 or 0.01 mM 24 hours To assess whether EF could attenuate H2O2-induced oxidative stress injury. Results showed that EF pretreatment attenuated H2O2-induced cell damage. Sci Rep. 2020 May 26;10(1):8688
Bone marrow-derived macrophages (BMDMs) 0, 3, 10, 30, 100 μM 0.5 hours To evaluate the inhibitory effect of EF on LPS-induced inflammatory response. EF significantly suppressed iNOS expression and NO production, and reduced mRNA expression of proinflammatory cytokines TNF-α, IL-1β, and IL-6. Acta Pharmacol Sin. 2021 Dec;42(12):2069-2081
RAW264.7 cells 0, 3, 10, 30, 100 μM 0.5 hours To evaluate the inhibitory effect of EF on LPS-induced inflammatory response. EF significantly suppressed iNOS expression and NO production, and reduced mRNA expression of proinflammatory cytokines TNF-α, IL-1β, and IL-6. Acta Pharmacol Sin. 2021 Dec;42(12):2069-2081
Rat aortic smooth muscle cells (A10 cells) 1 and 10 μM 48 hours To investigate the effect of FAEE on leptin-induced migration of A10 cells, results showed that FAEE significantly inhibited leptin-induced cell migration. Exp Mol Med. 2015 Aug 28;47(8):e180
Primary microglia 10, 20, 50 μmol 2 hours pretreatment followed by LPS stimulation for 24 hours EF significantly suppressed LPS-induced expression of IL-1β, IL-6, TNF-α, iNOS and COX-2 in primary microglia and reduced NO release Front Pharmacol. 2022 Oct 13;13:1004215
BV2 cells 10, 20, 50 μmol 2 hours pretreatment followed by LPS stimulation EF significantly suppressed LPS-induced pro-inflammatory response and NF-κB pathway in BV2 cells Front Pharmacol. 2022 Oct 13;13:1004215
RAW 264.7 cells 25, 50, 100 μM 5 days Evaluate the effect of FAEE on osteoclast formation, results showed FAEE dose-dependently inhibited the formation of TRAP-positive multinucleated osteoclasts Pharm Biol. 2022 Dec;60(1):467-478
RAW 264.7 cells 25, 50, 100 μM 48 hours Assess cell viability, results showed 200 μM FAEE significantly reduced cell viability, thus 25, 50, 100 μM were selected for further experiments Pharm Biol. 2022 Dec;60(1):467-478

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice LPS-induced acute lung injury (ALI) model Intraperitoneal injection 25 mg/kg, 50 mg/kg Single dose, evaluated after 6 hours To evaluate the protective effect of EF on LPS-induced ALI. EF significantly alleviated lung pathological damage, reduced neutrophil infiltration, and decreased mRNA expression of proinflammatory cytokines TNF-α, IL-1β, and IL-6. Acta Pharmacol Sin. 2021 Dec;42(12):2069-2081
C57BL/6 male mice Transient middle cerebral artery occlusion (tMCAO) model Intraperitoneal injection 15 mg/kg At 30 min, 24 h and 48 h post-surgery, for 3 days EF significantly alleviated neuroinflammation and microglial activation in the tMCAO model, reduced infarct volume and improved neurological deficits Front Pharmacol. 2022 Oct 13;13:1004215
C57BL/6 mice NaIO3-induced retinal degeneration model Oral 30 mg/kg/day From 3 days before NaIO3 injection to 14 days after, daily administration To evaluate the protective effect of EF on NaIO3-induced retinal degeneration. Results showed that EF treatment attenuated NaIO3-induced retinal dysfunction and increased ERG responses. Sci Rep. 2020 May 26;10(1):8688

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.50mL

0.90mL

0.45mL

22.50mL

4.50mL

2.25mL

45.00mL

9.00mL

4.50mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories